Besides, tumor endothelial cells express soluble ICAM-5, which functions as an inhibitor of LFA-1, counteracting the pro-inflammatory effects of ICAM-1 by reducing the activation of T lymphocytes (65). This evidence concerns the gene ICAM1 and neoplasm.